GKAP1
gene geneOn this page
Also known as GKAP42FKSG21
Summary
GKAP1 (G kinase anchoring protein 1, HGNC:17496) is a protein-coding gene on chromosome 9q21.32, encoding G kinase-anchoring protein 1 (Q5VSY0). Regulates insulin-dependent IRS1 tyrosine phosphorylation in adipocytes by modulating the availability of IRS1 to IR tyrosine kinase.
This gene encodes a protein that is highly similar to the mouse cGMP-dependent protein kinase anchoring protein 42kDa. The mouse protein has been found to localize with the Golgi and recruit cGMP-dependent protein kinase I alpha to the Golgi in mouse testes. It is thought to play a role in germ cell development. Transcript variants encoding different isoforms have been found for this gene.
Source: NCBI Gene 80318 — RefSeq curated summary.
At a glance
- GWAS associations: 8
- Clinical variants (ClinVar): 61 total
- MANE Select transcript:
NM_025211
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:17496 |
| Approved symbol | GKAP1 |
| Name | G kinase anchoring protein 1 |
| Location | 9q21.32 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | GKAP42, FKSG21 |
| Ensembl gene | ENSG00000165113 |
| Ensembl biotype | protein_coding |
| OMIM | 611356 |
| Entrez | 80318 |
Gene structure
Transcript identifiers
Ensembl transcripts: 19 — 15 protein_coding, 3 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay
ENST00000376362, ENST00000376365, ENST00000376371, ENST00000388782, ENST00000462223, ENST00000485742, ENST00000491634, ENST00000889366, ENST00000962685, ENST00000962686, ENST00000962687, ENST00000962688, ENST00000962689, ENST00000962690, ENST00000962691, ENST00000962692, ENST00000962693, ENST00000962694, ENST00000962695
RefSeq mRNA: 2 — MANE Select: NM_025211
NM_001135953, NM_025211
CCDS: CCDS35049, CCDS47988
Canonical transcript exons
ENST00000376371 — 13 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001090466 | 83748309 | 83748372 |
| ENSE00001090472 | 83799185 | 83799328 |
| ENSE00001173712 | 83739425 | 83739744 |
| ENSE00001289016 | 83817517 | 83817769 |
| ENSE00001289038 | 83753258 | 83753359 |
| ENSE00001289069 | 83816996 | 83817127 |
| ENSE00001376113 | 83806302 | 83806560 |
| ENSE00001503948 | 83768818 | 83768970 |
| ENSE00003479598 | 83742530 | 83742600 |
| ENSE00003554967 | 83741952 | 83742029 |
| ENSE00003598667 | 83780382 | 83780404 |
| ENSE00003599755 | 83788601 | 83788678 |
| ENSE00003672866 | 83784715 | 83784838 |
Expression profiles
Bgee: expression breadth ubiquitous, 251 present calls, max score 99.85.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 4.5647 / max 82.5033, expressed in 1157 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 101152 | 3.2071 | 1012 |
| 101153 | 1.2395 | 651 |
| 101151 | 0.0679 | 19 |
| 205537 | 0.0502 | 16 |
Top tissues by expression
255 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 99.85 | gold quality |
| secondary oocyte | CL:0000655 | 98.68 | gold quality |
| left testis | UBERON:0004533 | 98.57 | gold quality |
| right testis | UBERON:0004534 | 98.38 | gold quality |
| adult organism | UBERON:0007023 | 97.83 | gold quality |
| testis | UBERON:0000473 | 97.11 | gold quality |
| vastus lateralis | UBERON:0001379 | 96.39 | gold quality |
| quadriceps femoris | UBERON:0001377 | 96.16 | gold quality |
| biceps brachii | UBERON:0001507 | 95.44 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 95.24 | gold quality |
| deltoid | UBERON:0001476 | 94.76 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 94.74 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 94.36 | gold quality |
| oocyte | CL:0000023 | 94.04 | gold quality |
| tibialis anterior | UBERON:0001385 | 93.52 | gold quality |
| gastrocnemius | UBERON:0001388 | 93.29 | gold quality |
| muscle tissue | UBERON:0002385 | 93.14 | gold quality |
| buccal mucosa cell | CL:0002336 | 93.06 | gold quality |
| muscle of leg | UBERON:0001383 | 92.84 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 92.52 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 92.37 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 92.12 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 91.96 | silver quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 91.91 | gold quality |
| ventricular zone | UBERON:0003053 | 90.14 | gold quality |
| medial globus pallidus | UBERON:0002477 | 89.86 | gold quality |
| heart right ventricle | UBERON:0002080 | 89.41 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 89.33 | silver quality |
| calcaneal tendon | UBERON:0003701 | 88.94 | gold quality |
| globus pallidus | UBERON:0001875 | 88.86 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-124263 | yes | 512.52 |
| E-GEOD-134144 | yes | 30.43 |
| E-ANND-3 | yes | 4.89 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): STAT3
miRNA regulators (miRDB)
57 targeting GKAP1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6077 | 99.99 | 68.04 | 2299 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-1468-3P | 99.96 | 72.74 | 3797 |
| HSA-MIR-548J-3P | 99.94 | 72.61 | 4881 |
| HSA-MIR-548AE-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-548AH-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AM-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AQ-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-106A-5P | 99.90 | 73.94 | 2683 |
| HSA-MIR-17-5P | 99.89 | 73.83 | 2665 |
| HSA-MIR-106B-5P | 99.88 | 74.72 | 2795 |
| HSA-MIR-20A-5P | 99.88 | 74.76 | 2769 |
| HSA-MIR-20B-5P | 99.88 | 74.01 | 2621 |
| HSA-MIR-519D-3P | 99.88 | 73.97 | 2607 |
| HSA-MIR-526B-3P | 99.88 | 74.06 | 2587 |
| HSA-MIR-93-5P | 99.88 | 73.98 | 2606 |
| HSA-MIR-4503 | 99.85 | 71.45 | 1869 |
| HSA-MIR-548AR-3P | 99.85 | 71.26 | 3889 |
| HSA-MIR-548AZ-3P | 99.82 | 70.56 | 3549 |
| HSA-MIR-548BC | 99.82 | 70.61 | 3524 |
| HSA-MIR-548E-3P | 99.82 | 70.59 | 3514 |
| HSA-MIR-548F-3P | 99.82 | 70.59 | 3540 |
| HSA-MIR-4659A-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4659B-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-548AJ-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-548F-5P | 99.78 | 71.02 | 3093 |
| HSA-MIR-548G-5P | 99.78 | 71.12 | 3085 |
Literature-anchored findings (GeneRIF, showing 1)
- This paper describes the protein interaction, expression, localization and function of a highly similar gene in mouse. (PMID:10671526)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | gkap1 | ENSDARG00000068123 |
| mus_musculus | Gkap1 | ENSMUSG00000021552 |
| rattus_norvegicus | Gkap1 | ENSRNOG00000019272 |
Protein
Protein identifiers
G kinase-anchoring protein 1 — Q5VSY0 (reviewed: Q5VSY0)
Alternative names: cGMP-dependent protein kinase-anchoring protein of 42 kDa
All UniProt accessions (3): B4DXS0, C9J9D2, Q5VSY0
UniProt curated annotations — full annotation on UniProt →
Function. Regulates insulin-dependent IRS1 tyrosine phosphorylation in adipocytes by modulating the availability of IRS1 to IR tyrosine kinase. Its association with IRS1 is required for insulin-induced translocation of SLC2A4 to the cell membrane. Involved in TNF-induced impairment of insulin-dependent IRS1 tyrosine phosphorylation.
Subunit / interactions. Interacts with PRKG1 and IRS1.
Subcellular location. Golgi apparatus.
Similarity. Belongs to the GKAP1 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5VSY0-1 | 1 | yes |
| Q5VSY0-2 | 2 |
RefSeq proteins (2): NP_001129425, NP_079487* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR026109 | GKAP1 | Family |
UniProt features (14 total): modified residue 4, region of interest 3, coiled-coil region 3, chain 1, splice variant 1, sequence conflict 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5VSY0-F1 | 72.22 | 0.42 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (4): 27, 106, 23, 25
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 157 (showing top):
GOBP_RESPONSE_TO_NITROGEN_COMPOUND, BENPORATH_ES_WITH_H3K27ME3, PEREZ_TP63_TARGETS, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP, GOBP_CELLULAR_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND, GOBP_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS, GOBP_CELLULAR_RESPONSE_TO_HORMONE_STIMULUS, MILI_PSEUDOPODIA_HAPTOTAXIS_UP, GOBP_RESPONSE_TO_INSULIN, BILD_E2F3_ONCOGENIC_SIGNATURE, GOBP_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND, GOBP_POSITIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS, GOBP_CELLULAR_RESPONSE_TO_NITROGEN_COMPOUND, GOBP_RESPONSE_TO_HORMONE
GO Biological Process (3): signal transduction (GO:0007165), obsolete cGMP-mediated signaling (GO:0019934), positive regulation of insulin receptor signaling pathway (GO:0046628)
GO Molecular Function (3): identical protein binding (GO:0042802), protein binding (GO:0005515), kinase activity (GO:0016301)
GO Cellular Component (1): Golgi apparatus (GO:0005794)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| insulin receptor signaling pathway | 1 |
| positive regulation of signal transduction | 1 |
| regulation of insulin receptor signaling pathway | 1 |
| positive regulation of cellular response to insulin stimulus | 1 |
| protein binding | 1 |
| binding | 1 |
| transferase activity, transferring phosphorus-containing groups | 1 |
| cytoplasm | 1 |
| endomembrane system | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
338 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GKAP1 | PRKG1 | P14619 | 875 |
| GKAP1 | KIF27 | Q86VH2 | 579 |
| GKAP1 | ITGA2B | P08514 | 549 |
| GKAP1 | QNG1 | Q5T6V5 | 526 |
| GKAP1 | TSACC | Q96A04 | 522 |
| GKAP1 | C22orf23 | Q9BZE7 | 507 |
| GKAP1 | VWF | P04275 | 496 |
| GKAP1 | IRS1 | P35568 | 495 |
| GKAP1 | CATSPERT | Q53TS8 | 479 |
| GKAP1 | ACTRT2 | Q8TDY3 | 447 |
| GKAP1 | CD34 | P28906 | 423 |
| GKAP1 | ODAD4 | Q96NG3 | 410 |
| GKAP1 | TMEM229A | B2RXF0 | 399 |
| GKAP1 | CCDC54 | Q8NEL0 | 398 |
| GKAP1 | GARIN1B | Q96KD3 | 391 |
IntAct
76 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GKAP1 | GKAP1 | psi-mi:“MI:0915”(physical association) | 0.670 |
| DYR | GKAP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GKAP1 | MFAP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GKAP1 | HDDC3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GKAP1 | DYR | psi-mi:“MI:0915”(physical association) | 0.560 |
| MFAP1 | GKAP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HDDC3 | GKAP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GKAP1 | GCD7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GKAP1 | PSH1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PSH1 | GKAP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GCD7 | GKAP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GKAP1 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| GKAP1 | ZCCHC10 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GKAP1 | L3MBTL2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GKAP1 | PHOSPHO2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GKAP1 | KANK2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GKAP1 | KAT5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GKAP1 | RCOR3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SDCBP | GKAP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (61): GKAP1 (Two-hybrid), GKAP1 (Two-hybrid), GKAP1 (Two-hybrid), HDDC3 (Two-hybrid), GKAP1 (Two-hybrid), GKAP1 (Two-hybrid), GKAP1 (Affinity Capture-MS), GKAP1 (Proximity Label-MS), GKAP1 (Affinity Capture-MS), GKAP1 (Affinity Capture-MS), GKAP1 (Affinity Capture-MS), GKAP1 (Affinity Capture-MS), GKAP1 (Affinity Capture-MS), GKAP1 (Affinity Capture-MS), GKAP1 (Affinity Capture-MS)
ESM2 similar proteins: A4PB26, D3ZTQ1, G1SW77, O16053, O88271, Q12872, Q32LE2, Q3MHS2, Q3U155, Q3USH5, Q4ADK4, Q4ADK7, Q4VAA2, Q5M8L3, Q5PQP2, Q5PQS7, Q5RKH3, Q5VSY0, Q5XHI2, Q5XIG5, Q5XIM5, Q5ZLH9, Q60FC2, Q63ZM9, Q6AXS5, Q6DIS2, Q6DJ13, Q6GNQ4, Q6NWC9, Q6PFK1, Q75UQ2, Q7T370, Q7ZYA6, Q8HXY9, Q8K039, Q8MMC4, Q8NC51, Q8R1N0, Q92733, Q96NB3
Diamond homologs: Q32LE2, Q5M8L3, Q5VSY0, Q5XIG5, Q6GNQ4, Q6NWC9, Q8AVX1, Q9JMB0
SIGNOR signaling
3 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| “Cullin 1-RBX1-Skp1” | “down-regulates quantity by destabilization” | GKAP1 | polyubiquitination |
| PRKG1 | unknown | GKAP1 | phosphorylation |
| TRIM3 | “down-regulates quantity by destabilization” | GKAP1 | polyubiquitination |
Disease & clinical
Clinical variants and AI predictions
ClinVar
61 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 41 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2386 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:83742601:C:CC | acceptor_gain | 1.0000 |
| 9:83748307:A:AC | donor_gain | 1.0000 |
| 9:83748308:C:CC | donor_gain | 1.0000 |
| 9:83753259:T:TA | donor_gain | 1.0000 |
| 9:83753260:C:A | donor_gain | 1.0000 |
| 9:83753305:T:A | donor_gain | 1.0000 |
| 9:83753356:CTTC:C | acceptor_gain | 1.0000 |
| 9:83753357:TTC:T | acceptor_gain | 1.0000 |
| 9:83753358:TC:T | acceptor_gain | 1.0000 |
| 9:83753359:CC:C | acceptor_gain | 1.0000 |
| 9:83753360:C:CC | acceptor_gain | 1.0000 |
| 9:83753360:C:CG | acceptor_loss | 1.0000 |
| 9:83784710:ATTAC:A | donor_loss | 1.0000 |
| 9:83784711:TTA:T | donor_loss | 1.0000 |
| 9:83784712:TA:T | donor_loss | 1.0000 |
| 9:83784713:A:AT | donor_loss | 1.0000 |
| 9:83784714:C:CG | donor_loss | 1.0000 |
| 9:83784717:T:A | donor_gain | 1.0000 |
| 9:83784834:TACTC:T | acceptor_gain | 1.0000 |
| 9:83784836:CTC:C | acceptor_gain | 1.0000 |
| 9:83784837:TC:T | acceptor_gain | 1.0000 |
| 9:83784838:CC:C | acceptor_gain | 1.0000 |
| 9:83784838:CCTAA:C | acceptor_loss | 1.0000 |
| 9:83784839:C:A | acceptor_loss | 1.0000 |
| 9:83784839:C:CC | acceptor_gain | 1.0000 |
| 9:83784840:T:G | acceptor_loss | 1.0000 |
| 9:83788679:C:CC | acceptor_gain | 1.0000 |
| 9:83799173:A:AC | donor_gain | 1.0000 |
| 9:83799174:C:CC | donor_gain | 1.0000 |
| 9:83799177:A:AC | donor_gain | 1.0000 |
AlphaMissense
2413 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:83742540:A:G | L322P | 1.000 |
| 9:83742011:C:G | A332P | 0.999 |
| 9:83742019:A:G | L329P | 0.999 |
| 9:83742589:C:G | A306P | 0.999 |
| 9:83788650:A:G | L130P | 0.999 |
| 9:83799205:A:G | W114R | 0.999 |
| 9:83799205:A:T | W114R | 0.999 |
| 9:83799311:A:C | F78L | 0.999 |
| 9:83799311:A:T | F78L | 0.999 |
| 9:83799313:A:G | F78L | 0.999 |
| 9:83799315:G:T | A77D | 0.999 |
| 9:83806470:A:C | F16L | 0.999 |
| 9:83806470:A:T | F16L | 0.999 |
| 9:83806471:A:G | F16S | 0.999 |
| 9:83806472:A:G | F16L | 0.999 |
| 9:83741993:A:G | S338P | 0.998 |
| 9:83742579:A:G | L309P | 0.998 |
| 9:83748323:A:G | L297P | 0.998 |
| 9:83748335:A:G | L293S | 0.998 |
| 9:83788642:C:G | A133P | 0.998 |
| 9:83799203:C:A | W114C | 0.998 |
| 9:83799203:C:G | W114C | 0.998 |
| 9:83799327:A:G | L73P | 0.998 |
| 9:83799327:A:T | L73H | 0.998 |
| 9:83806462:A:G | L19S | 0.998 |
| 9:83742540:A:T | L322H | 0.997 |
| 9:83748346:T:A | R289S | 0.997 |
| 9:83748346:T:G | R289S | 0.997 |
| 9:83788628:A:C | S137R | 0.997 |
| 9:83788628:A:T | S137R | 0.997 |
dbSNP variants (sampled 300 via entrez): RS1000001796 (9:83818111 C>T), RS1000019476 (9:83793571 A>G), RS1000019521 (9:83791912 G>C), RS1000110095 (9:83812977 CT>C,CTT), RS1000131124 (9:83755248 A>G), RS1000171899 (9:83746751 A>C), RS1000181281 (9:83743216 T>C,G), RS1000191189 (9:83758086 T>TTG), RS1000224863 (9:83754954 G>A,T), RS1000272735 (9:83795230 T>A), RS1000303295 (9:83802851 G>C), RS1000332493 (9:83739219 T>C), RS1000337957 (9:83761323 A>G), RS1000348070 (9:83783371 C>A,G), RS1000356698 (9:83803103 C>A)
Disease associations
OMIM: gene MIM:611356 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
8 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004600_77 | Eosinophil percentage of white cells | 9.000000e-12 |
| GCST004617_168 | Eosinophil percentage of granulocytes | 8.000000e-12 |
| GCST004623_124 | Neutrophil percentage of granulocytes | 6.000000e-11 |
| GCST007576_54 | Chronotype | 2.000000e-10 |
| GCST010173_69 | Triglyceride levels | 3.000000e-14 |
| GCST011494_48 | Daytime nap | 3.000000e-11 |
| GCST90000047_197 | Age at first sexual intercourse | 2.000000e-09 |
| GCST90002381_476 | Eosinophil count | 5.000000e-17 |
EFO canonical traits (8, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007991 | eosinophil percentage of leukocytes |
| EFO:0007996 | eosinophil percentage of granulocytes |
| EFO:0007994 | neutrophil percentage of granulocytes |
| EFO:0008328 | chronotype measurement |
| EFO:0004530 | triglyceride measurement |
| EFO:0007828 | daytime rest measurement |
| EFO:0009749 | age at first sexual intercourse measurement |
| EFO:0004842 | eosinophil count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
37 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, decreases expression, affects expression, decreases methylation, increases expression | 9 |
| trichostatin A | affects cotreatment, decreases expression, increases expression | 3 |
| sodium arsenite | affects expression, decreases expression, increases expression | 3 |
| entinostat | decreases expression, affects cotreatment | 2 |
| Panobinostat | affects cotreatment, decreases expression | 2 |
| Nickel | decreases expression | 2 |
| GSK-J4 | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | increases expression | 1 |
| deoxynivalenol | increases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| bisphenol S | affects cotreatment, increases expression | 1 |
| jinfukang | affects cotreatment, decreases expression | 1 |
| (+)-JQ1 compound | increases expression | 1 |
| MT19c compound | increases expression | 1 |
| Bortezomib | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Amiodarone | increases expression | 1 |
| Cisplatin | decreases expression, affects cotreatment | 1 |
| Dexamethasone | affects cotreatment, increases expression | 1 |
| Estradiol | decreases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Indomethacin | affects cotreatment, increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 1 |
| Theophylline | increases expression | 1 |
| Tretinoin | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.